Literature DB >> 9806764

Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens.

M O Masuda1, M Levin, S F De Oliveira, P C Dos Santos Costa, P L Bergami, N A Dos Santos Almeida, R C Pedrosa, I Ferrari, J Hoebeke, A C Campos de Carvalho.   

Abstract

Antibodies of chronic chagasic patients have been shown to interfere with electric and mechanical activities of cardiac embryonic myocytes in culture and with whole mammalian hearts. A mechanism proposed for this effect involves interaction of the antibodies with G-protein-linked membrane receptors, thus leading to activation of beta adrenergic and muscarinic receptors; more specifically, IgG of chagasic patients would interact with the negatively charged regions of the second extracellular loop of these receptors. We performed competition experiments to test this hypothesis. We evaluated the effect of sera/IgG from patients previously known to depress electrogenesis and/or atrioventricular conduction in isolated rabbit hearts after incubation with live and lysed parasites, the peptide corresponding to the second extracellular loop (O2) of the M2 receptor, and different peptides derived from two ribosomal proteins of T. cruzi: P0 and P2beta. Our results indicate that 1) the antigenic factor inducing the functionally active IgGs in the chagasic patients is probably an intracellular T. cruzi antigen; 2) IgG/serum is interacting with the O2 region of the M2 receptor in the rabbit heart; and 3) the negative charges present in the ribosomal proteins of T. cruzi are important in mediating the interaction between the patients' serum/IgG and the receptor.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806764     DOI: 10.1096/fasebj.12.14.1551

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  10 in total

1.  Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease.

Authors:  N Gironès; C I Rodríguez; E Carrasco-Marín; R F Hernáez; J L de Rego; M Fresno
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

Review 2.  Role of autoantibodies in the physiopathology of Chagas' disease.

Authors:  Emiliano Horacio Medei; José Hamilton Matheus Nascimento; Roberto Coury Pedrosa; Antônio Carlos Campos de Carvalho
Journal:  Arq Bras Cardiol       Date:  2008-10       Impact factor: 2.000

3.  Design, construction, and evaluation of a specific chimeric antigen to diagnose chagasic infection.

Authors:  Sebastián Aguirre; Ariel M Silber; Maria Edileuza F Brito; María E Ribone; Claudia M Lagier; Iván S Marcipar
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

4.  The beta1 adrenergic effects of antibodies against the C-terminal end of the ribosomal P2beta protein of Trypanosoma cruzi associate with a specific pattern of epitope recognition.

Authors:  P Lopez Bergami; K A Gómez; G V Levy; V Grippo; A Baldi; M J Levin
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 5.  Chronic Chagas' heart disease: a disease on its way to becoming a worldwide health problem: epidemiology, etiopathology, treatment, pathogenesis and laboratory medicine.

Authors:  Silvia Gilka Muñoz-Saravia; Annekathrin Haberland; Gerd Wallukat; Ingolf Schimke
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

6.  Humoral immune response against P2β from Trypanosoma cruzi in persons with chronic Chagas disease: its relationship with treatment against parasites and myocardial damage.

Authors:  Diana L Fabbro; Verónica Olivera; Maria Laura Bizai; Susana Denner; Cristina Diez; Iván Marcipar; Iván Mancipar; Mirtha Streiger; Enrique Arias; Mónica del Barco; Diego Mendicino; Oscar Bottasso
Journal:  Am J Trop Med Hyg       Date:  2011-04       Impact factor: 2.345

7.  Autoantibodies enhance agonist action and binding to cardiac muscarinic receptors in chronic Chagas' disease.

Authors:  Ciria C Hernandez; Jose H Nascimento; Elen A Chaves; Patricia C Costa; Masako O Masuda; Eleonora Kurtenbach; Antonio C Campos DE Carvalho; Luis E Gimenez
Journal:  J Recept Signal Transduct Res       Date:  2008       Impact factor: 2.092

8.  Anti-beta1-adrenergic receptor autoantibodies in patients with chronic Chagas heart disease.

Authors:  V Labovsky; C R Smulski; K Gómez; G Levy; M J Levin
Journal:  Clin Exp Immunol       Date:  2007-04-05       Impact factor: 4.330

9.  Inflammation Enhances the Risks of Stroke and Death in Chronic Chagas Disease Patients.

Authors:  Paulo Marcos Matta Guedes; Cléber Mesquita de Andrade; Daniela Ferreira Nunes; Nathalie de Sena Pereira; Tamyres Bernadete Dantas Queiroga; George Luiz Lins Machado-Coelho; Manuela Sales Lima Nascimento; Maria Adelaide Do-Valle-Matta; Antônia Cláudia Jácome da Câmara; Egler Chiari; Lúcia Maria da Cunha Galvão
Journal:  PLoS Negl Trop Dis       Date:  2016-04-26

10.  Innate immune receptors over expression correlate with chronic chagasic cardiomyopathy and digestive damage in patients.

Authors:  Nathalie de Sena Pereira; Tamyres Bernadete Dantas Queiroga; Daniela Ferreira Nunes; Cléber de Mesquita Andrade; Manuela Sales Lima Nascimento; Maria Adelaide Do-Valle-Matta; Antônia Cláudia Jácome da Câmara; Lúcia Maria da Cunha Galvão; Paulo Marcos Matta Guedes; Egler Chiari
Journal:  PLoS Negl Trop Dis       Date:  2018-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.